Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.69 is 273% above its 5-year average of -0.40, near the high end of its 5-year range (-15.79–6.88).
As of the fiscal period ended Tuesday, June 30, 2026. 1422.01% above its 12-month average of -0.05.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.69.
DEBT TO EQUITY RATIO
0.69
DEBT TO EQUITY RATIO AVG TTM
-0.05
DEBT TO EQUITY RATIO AVG 3Y
-0.60
DEBT TO EQUITY RATIO AVG 5Y
-0.40
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+1422.01%
CURRENT VS 3Y AVG
+215.12%
CURRENT VS 5Y AVG
+272.85%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 711 covered companies
CURRENT VS SECTOR MEDIAN
+523.07%
vs the sector median at left
Market Cap
$34.58M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$35.10M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$33.74M
Debt to Equity Ratio
4.41
TTM Avg
3.29
3Y Avg
3.77
5Y Avg
3.62
Market Cap
$36.28M
Debt to Equity Ratio
1.93
TTM Avg
0.81
3Y Avg
0.39
5Y Avg
0.65
Market Cap
$33.66M
Debt to Equity Ratio
0.11
TTM Avg
0.10
3Y Avg
0.11
5Y Avg
0.10
Market Cap
$33.24M
Debt to Equity Ratio
N/A
TTM Avg
0.89
3Y Avg
0.89
5Y Avg
0.89
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elutia Inc (ELUT) | $34.76M | 0.69 | -0.05 | -0.60 | -0.40 |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.58M | 0.00 | 0.00 | 0.00 | 0.00 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.10M | 0.00 | 0.00 | 0.00 | 0.00 |
| Accuray Incorporated (ARAY)vs › | $33.74M | 4.41 | 3.29 | 3.77 | 3.62 |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.28M | 1.93 | 0.81 | 0.39 | 0.65 |
| DocGo Inc. (DCGO)vs › | $35.81M | 0.22 | 0.19 | 0.15 | 0.15 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.66M | 0.11 | 0.10 | 0.11 | 0.10 |
| HeartBeam, Inc. (BEAT)vs › | $33.25M | 0.00 | 0.00 | 0.00 | 0.00 |
| EUDA Health Holdings Limited (EUDA)vs › | $33.24M | N/A | 0.89 | 0.89 | 0.89 |
| Scilex Holding Company (SCLX)vs › | $33.03M | N/A | 0.04 | 0.04 | 0.04 |
Debt/Equity
0.69
Current Ratio
1.77
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.69 |
| 2026-03-31 | 0.19 |
| 2025-12-31 | 0.14 |
| 2025-09-30 | -0.60 |
| 2025-06-30 | -0.67 |
| 2025-03-31 | -0.69 |
| 2024-12-31 | -0.53 |
| 2024-09-30 | -0.57 |
| 2024-06-30 | -0.35 |
| 2024-03-31 | -0.44 |
| 2023-12-31 | -0.62 |
| 2023-09-30 | -0.87 |
| 2023-06-30 | -1.19 |
| 2023-03-31 | -2.14 |
| 2022-12-31 | -5.06 |
| 2022-09-30 | -3.97 |
| 2022-06-30 | -15.79 |
| 2022-03-31 | 6.88 |
| 2021-12-31 | 1.72 |
| 2021-09-30 | 2.81 |
